Determinants of platelet count in pediatric patients with congenital cyanotic heart disease: Role of immature platelet fraction

Congenital Heart Disease

Volumn 13, Issue 1, 2018, Pages 118-123

  Matter, Randa M ^a   Ragab, Iman A ^a   Roushdy, Alaa M ^a   Ahmed, Ahmed G ^a   Aly, Hanan H ^a   Ismail, Eman A ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

CCHD; immature platelet fraction; RET H; thrombocytopenia

Indexed keywords

C REACTIVE PROTEIN; HEMOGLOBIN; IRON; HOMEODOMAIN PROTEIN; PANCREATIC AND DUODENAL HOMEOBOX 1 PROTEIN; TRANSACTIVATOR PROTEIN;

ACTIVATED PARTIAL THROMBOPLASTIN TIME; ADOLESCENT; ARTICLE; BLOOD CELL COUNT; CHILD; CLINICAL ARTICLE; CORRELATIONAL STUDY; CROSS-SECTIONAL STUDY; CYANOTIC HEART DISEASE; ERYTHROCYTE COUNT; FEMALE; HEALTH SERVICE; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFANT; IRON BLOOD LEVEL; MALE; PATHOGENESIS; PLATELET COUNT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTHROMBIN TIME; RETICULOCYTE COUNT; THROMBOCYTOPENIA; THROMBOCYTOPOIESIS; BLOOD; BLOOD CLOTTING TEST; CONGENITAL HEART MALFORMATION; DOPPLER ECHOCARDIOGRAPHY; JAPAN; METABOLISM; MORBIDITY; NEWBORN; PARTIAL THROMBOPLASTIN TIME; PRESCHOOL CHILD; PROGNOSIS; SURVIVAL RATE; THROMBOCYTE; TRENDS;

BLOOD COAGULATION TESTS; BLOOD PLATELETS; C-REACTIVE PROTEIN; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HEART DEFECTS, CONGENITAL; HOMEODOMAIN PROTEINS; HUMANS; INFANT; INFANT, NEWBORN; JAPAN; MALE; MORBIDITY; PARTIAL THROMBOPLASTIN TIME; PLATELET COUNT; PROGNOSIS; PROTHROMBIN TIME; SURVIVAL RATE; THROMBOCYTOPENIA; TRANS-ACTIVATORS;

EID: 85028951071     PISSN: 1747079X     EISSN: 17470803     Source Type: Journal    
DOI: 10.1111/chd.12530     Document Type: Article

References (21)

1. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39(12):1890–1900.
2. Kumor-Kurek M, Siudalska H. [Hematologic disorders in patients with cyanotic congenital heart disease]. Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego. 1999;7(38):82–84.
3. Auluck A, Manohar C. Haematological considerations in patients with cyanotic congenital heart disease: a review. Dent Update. 2006;33(10):617–622.
4. Zabala LM, Guzzetta NA. Cyanotic congenital heart disease (CCHD): focus on hypoxemia, secondary erythrocytosis, and coagulation alterations. Paediatr Anaesth. 2015;25(10):981–989.
5. Goel M, Shome DK, Singh ZN, Bhattacharjee J, Khalil A. Haemostatic changes in children with cyanotic and acyanotic congenital heart disease. Indian Heart J. 2000;52(5):559–563.
6. Harrison P, Robinson MS, Mackie IJ, Machin SJ. Reticulated platelets. Platelets. 1997;8(6):379–383.
7. Richards EM, Baglin TP. Quantitation of reticulated platelets: methodology and clinical application. Br J Haematol. 1995;91(2):445–451.
8. Adly AA, Ragab IA, Ismail EA, Farahat MM. Evaluation of the immature platelet fraction in the diagnosis and prognosis of childhood immune thrombocytopenia. Platelets. 2015;26(7):645–650.
9. Cremer M, Weimann A, Szekessy D, Hammer H, Buhrer C, Dame C. Low immature platelet fraction suggests decreased megakaryopoiesis in neonates with sepsis or necrotizing enterocolitis. J Perinatol. 2013;33(8):622–626.
10. Cremer M, Weimann A, Schmalisch G, Hammer H, Buhrer C, Dame C. Immature platelet values indicate impaired megakaryopoietic activity in neonatal early-onset thrombocytopenia. Thromb Haemost. 2010;103(5):1016–1021.
11. Brugnara C, Schiller B, Moran J. Reticulocyte hemoglobin equivalent (Ret He) and assessment of iron-deficient states. Clin Lab Haematol. 2006;28(5):303–308.
12. Tanner JM, Whitehouse RH, Takaishi M. Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. II. Arch Dis Child. 1966;41(220):613–635.
13. Snider A, Serwer G, Ritter S. Echocardiography in pediatric heart disease. St. Louis, MO, USA: Mosby; 1997.
14. Roushdy A, Fiky AE, Din DE. Visualization of patent ductus arteriosus using real-time three-dimensional echocardiogram: comparative study with 2D echocardiogram and angiography. J Saudi Heart Assoc. 2012;24(3):177–186.
15. Lill MC, Perloff JK, Child JS. Pathogenesis of thrombocytopenia in cyanotic congenital heart disease. Am J Cardiol. 2006;98(2):254–258.
16. Jensen AS, Johansson PI, Idorn L, et al. The haematocrit–an important factor causing impaired haemostasis in patients with cyanotic congenital heart disease. Int J Cardiol. 2013;167(4):1317–1321.
17. van der Linden N, Klinkenberg LJ, Meex SJ, Beckers EA, de Wit NC, Prinzen L. Immature platelet fraction measured on the Sysmex XN hemocytometer predicts thrombopoietic recovery after autologous stem cell transplantation. Eur J Haematol. 2014;93(2):150–156.
18. Ismail EA, Youssef OI. Platelet-derived microparticles and platelet function profile in children with congenital heart disease. Clin Appl Thromb Hemost. 2013;19(4):424–432.
19. Goldschmidt B, Sarkadi B, Gardos G, Matlary A. Platelet production and survival in cyanotic congenital heart disease. Scand J Haematol. 1974;13(2):110–115.
20. Henriksson P, Varendh G, Lundstrom NR. Haemostatic defects in cyanotic congenital heart disease. Br Heart J. 1979;41(1):23–27.
21. Horigome H, Hiramatsu Y, Shigeta O, Nagasawa T, Matsui A. Overproduction of platelet microparticles in cyanotic congenital heart disease with polycythemia. J Am Coll Cardiol. 2002;39(6):1072–1077.